Bernard Gołko

Chief Executive Officer

An experienced leader in the medtech and financial sectors, as well as an investor with extensive experience in venture capital and scaling innovative technology companies. 

Previously, as CEO of QVITI S.A., he developed certified neurostimulation devices and a therapeutic platform combining VR with neuromodulation, aimed among others at patients with neurodegenerative diseases. He has also been associated with the financial sector (includingHSBC, Citibank, and Credit Agricole), where he worked on digital transformation, as well as with venture capital funds. 

He is a co-creator of the AgeTech Polska initiative and the AgeTech.pl platform – one of Poland’s key hubs for knowledge and debate on technologies supporting healthy aging and the longevity economy. He also lectured at the Polish-Japanese Academy of Information Technology, sharing his expertise in innovation and technology entrepreneurship. 

As CEO of Hemolens Diagnostics, Bernard focuses on setting up the company’s strategic direction, combining his operational, investment, and technological experience with a passion for solving real social challenges through science and innovation.